The results of this study showed that HI NK cells, in particular the CD56bright subset, had strong cytotoxicity against certain HCC cell lines which expressed NKG2D ligands and FAS, supporting potential cancer immunotherapy using HI NK cells. The gene discussed is FAS; the disease is hepatocellular carcinoma.